These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21112155)

  • 1. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
    Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
    Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
    Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
    Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
    Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.
    Baltieri DA; de Andrade AG
    Braz J Psychiatry; 2003 Sep; 25(3):156-9. PubMed ID: 12975689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
    Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
    Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
    Kampman KM; Pettinati HM; Lynch KG; Xie H; Dackis C; Oslin DW; Sparkman T; Sharkoski T; O'Brien CP
    Addict Behav; 2009; 34(6-7):581-6. PubMed ID: 19345510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
    Chick J; Howlett H; Morgan MY; Ritson B
    Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
    Poldrugo F
    Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
    Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
    JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.